Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis

BJU International

Volumn 98, Issue 5, 2006, Pages 1090-1093

  Zu, Xiongbing ^a   Tang, Zhengyan ^a   Li, Yuan ^a   Gao, Ning ^a   Ding, Jian ^a   Qi, Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bladder TCC; Lymph node metastasis; Prognosis; VEGF C

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33749578614     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06446.x     Document Type: Article

References (14)

1. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003; 169: 943-5
2. Olofsson B, Pajusola K, Kaipainen A et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996; 93: 2576-81
3. Shida A, Fujioka S, Kobayashi K et al. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol 2006; 11: 38-43
4. Meyer M, Clauss M, Lepple-Wienhues A et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGFE, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 1999; 18: 363-74
5. Roberts N, Kloos B, Cassella M et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 2006; 66: 2650-7
6. Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566-70
7. Bando H, Weich HA, Horiguchi S, Funata N, Ogawa T, Toi M. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Oncol Rep 2006; 15: 653-9
8. Duff SE, Jeziorska M, Rosa DD et al. Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy. Eur J Cancer 2006; 42: 112-7
9. Moskaluk CA. Standardization of clinical immunohistochemistry: why, how, and by whom? Am J Clin Pathol 2002; 118: 669-71
10. Hung CJ, Ginzinger DG, Zarnegar R et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 2003; 88: 3694-9
11. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003; 97: 457-64
12. Fujimoto J, Toyoki H, Sato E, Sakaguchi H, Tamaya T. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004; 91: 466-9
13. Gunningham SP, Currie MJ, Han C et al. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 2000; 6: 4278-86
14. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Honigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003; 32: 455-60